Stephanie L Sherman1, Sharon A Kidd2, Catharine Riley3, Elizabeth Berry-Kravis4,5,6, Howard F Andrews7, Robert M Miller2, Sharyn Lincoln8, Mark Swanson3, Walter E Kaufmann9,10, W Ted Brown11. 1. Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia; ssherma@emory.edu. 2. National Fragile X Foundation, Washington, District of Columbia. 3. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia. 4. Departments of Pediatrics. 5. Neurological Sciences, and. 6. Biochemistry, Rush University Medical Center, Chicago, Illinois. 7. Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York. 8. Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts. 9. Department of Neurology, Boston Children's Hospital, Boston Massachusetts. 10. Center for Translational Research, Greenwood Genetic Center, Greenwood, South Carolina; and. 11. Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York.
Abstract
BACKGROUND AND OBJECTIVE: Advances in the care of patients with fragile X syndrome (FXS) have been hampered by lack of data. This deficiency has produced fragmentary knowledge regarding the natural history of this condition, healthcare needs, and the effects of the disease on caregivers. To remedy this deficiency, the Fragile X Clinic and Research Consortium was established to facilitate research. Through a collective effort, the Fragile X Clinic and Research Consortium developed the Fragile X Online Registry With Accessible Research Database (FORWARD) to facilitate multisite data collection. This report describes FORWARD and the way it can be used to improve health and quality of life of FXS patients and their relatives and caregivers. METHODS: FORWARD collects demographic information on individuals with FXS and their family members (affected and unaffected) through a 1-time registry form. The longitudinal database collects clinician- and parent-reported data on individuals diagnosed with FXS, focused on those who are 0 to 24 years of age, although individuals of any age can participate. RESULTS: The registry includes >2300 registrants (data collected September 7, 2009 to August 31, 2014). The longitudinal database includes data on 713 individuals diagnosed with FXS (data collected September 7, 2012 to August 31, 2014). Longitudinal data continue to be collected on enrolled patients along with baseline data on new patients. CONCLUSIONS: FORWARD represents the largest resource of clinical and demographic data for the FXS population in the United States. These data can be used to advance our understanding of FXS: the impact of cooccurring conditions, the impact on the day-to-day lives of individuals living with FXS and their families, and short-term and long-term outcomes.
BACKGROUND AND OBJECTIVE: Advances in the care of patients with fragile X syndrome (FXS) have been hampered by lack of data. This deficiency has produced fragmentary knowledge regarding the natural history of this condition, healthcare needs, and the effects of the disease on caregivers. To remedy this deficiency, the Fragile X Clinic and Research Consortium was established to facilitate research. Through a collective effort, the Fragile X Clinic and Research Consortium developed the Fragile X Online Registry With Accessible Research Database (FORWARD) to facilitate multisite data collection. This report describes FORWARD and the way it can be used to improve health and quality of life of FXSpatients and their relatives and caregivers. METHODS: FORWARD collects demographic information on individuals with FXS and their family members (affected and unaffected) through a 1-time registry form. The longitudinal database collects clinician- and parent-reported data on individuals diagnosed with FXS, focused on those who are 0 to 24 years of age, although individuals of any age can participate. RESULTS: The registry includes >2300 registrants (data collected September 7, 2009 to August 31, 2014). The longitudinal database includes data on 713 individuals diagnosed with FXS (data collected September 7, 2012 to August 31, 2014). Longitudinal data continue to be collected on enrolled patients along with baseline data on new patients. CONCLUSIONS: FORWARD represents the largest resource of clinical and demographic data for the FXS population in the United States. These data can be used to advance our understanding of FXS: the impact of cooccurring conditions, the impact on the day-to-day lives of individuals living with FXS and their families, and short-term and long-term outcomes.
Authors: S Yu; M Pritchard; E Kremer; M Lynch; J Nancarrow; E Baker; K Holman; J C Mulley; S T Warren; D Schlessinger Journal: Science Date: 1991-05-24 Impact factor: 47.728
Authors: Rebecca Kronk; Ellen E Bishop; Melissa Raspa; Julie O Bickel; Daniel A Mandel; Donald B Bailey Journal: Sleep Date: 2010-05 Impact factor: 5.849
Authors: H J Smeets; A P Smits; C E Verheij; J P Theelen; R Willemsen; I van de Burgt; A T Hoogeveen; J C Oosterwijk; B A Oostra Journal: Hum Mol Genet Date: 1995-11 Impact factor: 6.150
Authors: Susan W Harris; David Hessl; Beth Goodlin-Jones; Jessica Ferranti; Susan Bacalman; Ingrid Barbato; Flora Tassone; Paul J Hagerman; Herman Herman; Randi J Hagerman Journal: Am J Ment Retard Date: 2008-11
Authors: Frank Haessler; Franziska Gaese; Michael Colla; Michael Huss; Christoph Kretschmar; Marc Brinkman; Heike Schieb; Helmut Peters; Samuel Elstner; David Pittrow Journal: BMC Psychiatry Date: 2013-12-19 Impact factor: 3.630
Authors: Kendra E Gilbertson; Hannah L Jackson; Eric J Dziuban; Stephanie L Sherman; Elizabeth M Berry-Kravis; Craig A Erickson; Rodolfo Valdez Journal: Disabil Health J Date: 2019-05-03 Impact factor: 2.554
Authors: Eleanor M Eckert; Kelli C Dominick; Ernest V Pedapati; Logan K Wink; Rebecca C Shaffer; Howard Andrews; Tse-Hwei Choo; Chen Chen; Walter E Kaufmann; Nicole Tartaglia; Elizabeth M Berry-Kravis; Craig A Erickson Journal: J Autism Dev Disord Date: 2019-11
Authors: Cara J Westmark; Chad Kniss; Emmanuel Sampene; Angel Wang; Amie Milunovich; Kelly Elver; David Hessl; Amy Talboy; Jonathon Picker; Barbara Haas-Givler; Amy Esler; Andrea L Gropman; Ryan Uy; Craig Erickson; Milen Velinov; Nicole Tartaglia; Elizabeth M Berry-Kravis Journal: Nutrients Date: 2020-10-14 Impact factor: 5.717
Authors: Elizabeth Berry-Kravis; Robyn A Filipink; Richard E Frye; Sailaja Golla; Stephanie M Morris; Howard Andrews; Tse-Hwei Choo; Walter E Kaufmann Journal: Front Pediatr Date: 2021-12-30 Impact factor: 3.418